Zeki Cetinkaya, Saban Kelesoglu, Aydin Tuncay, Yucel Yilmaz, Yucel Karaca, Mehdi Karasu, Ozlem Secen, Ahmet Cinar, Murat Harman, Seyda Sahin, Yusuf Akin, Ozkan Yavcin
BACKGROUND: Even though medication and interventional therapy have improved the death rate for non-ST elevation myocardial infarction (NSTEMI) patients, these patients still have a substantial residual risk of cardiovascular events. Early identification of high-risk individuals is critical for improving prognosis, especially in this patient group. The focus of recent research has switched to finding new related indicators that can help distinguish high-risk patients. For this purpose, we examined the relationship between the pan-immune-inflammation value (PIV) and the severity of coronary artery disease (CAD) defined by the SYNTAX score (SxS) in NSTEMI patients...
February 25, 2024: Journal of Clinical Medicine